TMCnet News
Stock to Watch: Cytokinetics Down 7.6% (CYTK)Feb 04, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Cytokinetics (NASDAQ:CYTK) is one of today's worst performing low-priced stocks, down 7.6% to $1.10 on 1.1x average daily volume. Thus far today, Cytokinetics has traded 672,000 shares, vs. average volume of 586,000 shares per day. The stock has underperformed the Dow (-7.6% to the Dow's -0.9%) and underperformed the S&P 500 (-7.6% to the S&P's -1.0%) during today's trading. Potential upside of 210.7% exists for Cytokinetics, based on a current level of $1.10 and analysts' average consensus price target of $3.42. The stock should discover initial support at its 50-day moving average (MA) of $0.82 and subsequent support at its 200-day MA of $0.80. In the past 52 weeks, Cytokinetics share prices have been bracketed by a low of $0.57 and a high of $1.29 and are now at $1.10, 93% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 6.4%. Cytokinetics, Incorporated is a biopharmaceutical company that combines life sciences and information technologies to accelerate and enhance the productivity of drug discovery and development. The Company focuses on the novel small molecule drugs that specifically target the cytoskeleton, a complex, dynamic framework that impacts all aspects of cell functions. SmarTrend recommended that subscribers consider buying shares of Cytokinetics on January 7th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $0.82. Since that recommendation, shares of Cytokinetics have risen 45.1%. We continue to monitor CYTK for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |